The phase 3 trial is in 8,000+ patients with established cardiovascular disease and elevated Lp(a) with a hard primary endpoint composite of cardiovascular death, myocardial infarction, stroke, or urgent coronary revascularization requiring hospitalization
Claire D'Abreu-Hayling, President, Generics Development and Chief Scientific Officer: Sandoz is building its GLP-1 development platform and this submission reflects true in-house innovation
Discussion The PK of semaglutide were well characterised by a two-compartment model with first-order absorption and elimination, and were shown to be predictable across clinical pharmacology and phase 3 trials and across subjects with low interindividual variation and low residual error
A successful program anticipates these realities and builds a plan that works in your actual weeknot an idealized one
10.1136/bmj.j5010 186
Overdose If you are prescribed Contrave or phentermine, it is important to take the medication exactly as directed